MedX Health Corp. Share Price Toronto S.E.
Equities
MDX
CA5850901037
Advanced Medical Equipment & Technology
Sales 2022 | 5L 4L 3.12Cr | Sales 2023 | 5L 3L 2.79Cr | Capitalization | 1.57Cr 1.15Cr 96Cr |
---|---|---|---|---|---|
Net income 2022 | -50L -36.51L -31Cr | Net income 2023 | -40L -29.21L -24Cr | EV / Sales 2022 | 22.1 x |
Net Debt 2022 | 48.55L 35.46L 30Cr | Net Debt 2023 | 57.06L 41.67L 35Cr | EV / Sales 2023 | 47 x |
P/E ratio 2022 |
-1.25
x | P/E ratio 2023 |
-2.58
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.77% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Lockyer
CEO | Chief Executive Officer | - | 25/23/25 |
Director of Finance/CFO | - | 29/22/29 | |
Bill Mitoulas
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hennigar
BRD | Director/Board Member | 84 | 19/01/19 |
Kenneth McKay
CHM | Chairman | - | 19/01/19 |
Stephen Lockyer
CEO | Chief Executive Officer | - | 25/23/25 |
1st Jan change | Capi. | |
---|---|---|
+4.57% | 21TCr | |
+8.61% | 19TCr | |
+26.34% | 16TCr | |
+33.90% | 11TCr | |
+2.17% | 6.55TCr | |
+14.50% | 5.29TCr | |
-3.30% | 4.53TCr | |
-3.98% | 3.97TCr | |
+6.66% | 3.77TCr |